Minority patients ignored in HIV drug trials.
Using a snapshot representing all HIV patients in the United States, researchers found that African-Americans and Latinos had substantially less access to clinical trials than were whites. 'This was true even when they had comparable health insurance, socioeconomic status, and education to whites,' says Allen L. Gifford, MD, assistant professor of medicine at the VA Healthcare System in San Diego. The analysis was conducted as part of the RAND-led HIV Cost and Services Utilization Study Consortium, which is sponsored by the Agency for Healthcare Research and Quality in Rockville, MD.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008913:Minority Groups; D018579:Patient Selection
D019380:Anti-HIV Agents